NLS Pharmaceutics AG (NLSP) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    NLS Pharmaceutics AG

    NASDAQ: NLSP · Real-Time Price · USD
    2.00
    -0.12 (-5.66%)
    At close: Oct 03, 2025, 3:59 PM
    1.98
    -0.75%
    After-hours: Oct 03, 2025, 07:41 PM EDT

    NLS Pharmaceutics Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 1.67M 897.68K 8.95M 5.43M
    Short-Term Investments
    		 n/a n/a n/a n/a
    Long-Term Investments
    		 n/a n/a n/a n/a
    Other Long-Term Assets
    		 283.00 16.89K 12.14K 12.04K
    Receivables
    		 400K 10.66K 41.24K 38.55K
    Inventory
    		 n/a n/a -41.24K -38.55K
    Other Current Assets
    		 49.48K 845.7K 106.98K 76.09K
    Total Current Assets
    		 2.23M 1.82M 9.25M 5.72M
    Property-Plant & Equipment
    		 7.29K 6.69K 18.1K 29.51K
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 7.57K 23.58K 30.25K 41.55K
    Total Assets
    		 2.23M 1.85M 9.28M 5.76M
    Account Payables
    		 515.49K 4.63M 2.37M 1.74M
    Deferred Revenue
    		 n/a n/a n/a n/a
    Short-Term Debt
    		 n/a 1.63M n/a n/a
    Other Current Liabilities
    		 n/a 112.64K 8.89K n/a
    Total Current Liabilities
    		 826.76K 7.92M 3.36M 2.4M
    Long-Term Debt
    		 n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 n/a 260.69K 136.12K 318.89K
    Total Long-Term Liabilities
    		 n/a 2.76M 2.64M 2.82M
    Total Liabilities
    		 826.76K 10.68M 6M 5.22M
    Total Debt
    		 n/a 1.63M n/a n/a
    Book Value
    		 1.41M -8.83M 3.28M 542.39K
    Book Value Per Share
    		 1.87 -0.23 0.17 0.04
    Common Stock
    		 166.35K 733.41K 668.55K 344.44K
    Retained Earnings
    		 -74.43M -70.37M -58.2M -41.71M
    Comprehensive Income
    		 108.85K -158.07K -50.79K -151.74K
    Shareholders Equity
    		 1.41M -8.83M 3.28M 542.39K
    Total Investments
    		 n/a n/a n/a n/a

    Add to Watchlist